SCN1A and Parkinson disease: Even if the role of GABAergic transmission in PD is still unknown, it is possible to speculate that the observed effect of phenytoin could result from blocking the increased activity of Nav1.1 in the globus pallidus thus restoring the physiological GABAergic activity.